Free Trial
NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

Nutex Health logo
$119.40 -2.89 (-2.36%)
Closing price 07/3/2025 03:51 PM Eastern
Extended Trading
$120.40 +1.00 (+0.84%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nutex Health Stock (NASDAQ:NUTX)

Key Stats

Today's Range
$111.14
$128.80
50-Day Range
$104.81
$177.21
52-Week Range
$4.16
$184.28
Volume
326,650 shs
Average Volume
86,755 shs
Market Capitalization
$663.86 million
P/E Ratio
10.04
Dividend Yield
N/A
Price Target
$262.50
Consensus Rating
Buy

Company Overview

Nutex Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

NUTX MarketRank™: 

Nutex Health scored higher than 71% of companies evaluated by MarketBeat, and ranked 271st out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nutex Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Nutex Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutex Health is 10.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.65.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutex Health is 10.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.64.

  • Price to Book Value per Share Ratio

    Nutex Health has a P/B Ratio of 3.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Nutex Health's valuation and earnings.
  • Percentage of Shares Shorted

    10.26% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently increased by 69.80%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nutex Health does not currently pay a dividend.

  • Dividend Growth

    Nutex Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.26% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently increased by 69.80%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nutex Health has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Nutex Health this week, compared to 2 articles on an average week.
  • Search Interest

    Only 8 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of -11% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutex Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $81,810.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    36.92% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.32% of the stock of Nutex Health is held by institutions.

  • Read more about Nutex Health's insider trading history.
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

NUTX Stock News Headlines

NUTX - Nutex Health Inc Valuation - Morningstar
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

NUTX Stock Analysis - Frequently Asked Questions

Nutex Health's stock was trading at $31.69 at the start of the year. Since then, NUTX shares have increased by 276.8% and is now trading at $119.40.

Nutex Health Inc. (NASDAQ:NUTX) announced its quarterly earnings results on Tuesday, May, 13th. The company reported $2.56 EPS for the quarter, beating the consensus estimate of ($0.15) by $2.71. The company earned $211.79 million during the quarter, compared to analyst estimates of $81.09 million. Nutex Health had a trailing twelve-month return on equity of 42.08% and a net margin of 10.76%.
Read the conference call transcript
.

Nutex Health shares reverse split before market open on Wednesday, July 3rd 2024.The 1-10 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutex Health investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Cricut (CRCT).

Company Calendar

Last Earnings
5/13/2025
Today
7/05/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:NUTX
Employees
1,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$262.50
High Stock Price Target
$300.00
Low Stock Price Target
$225.00
Potential Upside/Downside
+119.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
10.04
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$52.18 million
Pretax Margin
27.66%

Debt

Sales & Book Value

Annual Sales
$479.95 million
Cash Flow
$13.28 per share
Price / Cash Flow
8.99
Book Value
$37.13 per share
Price / Book
3.22

Miscellaneous

Free Float
3,504,000
Market Cap
$663.86 million
Optionable
Not Optionable
Beta
-0.04
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:NUTX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners